55 results
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
28 Mar 24
Cocrystal Pharma Reports 2023 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
8:00am
, Australia and global economies, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
13 Nov 23
Cocrystal Pharma Reports Third Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:15am
, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions and other business interruptions on our
8-K
EX-99.1
COCP
Cocrystal Pharma Inc
16 Aug 23
Cocrystal Pharma Reports Second Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
4:05pm
, including manufacturing and research delays arising from raw materials and labor shortages, supply chain disruptions and other business interruptions … including any adverse impacts on our ability to obtain raw materials and test animals as well as similar problems with our vendors and our current
424B5
7rwoh4ji55tah0c
15 Jun 23
Prospectus supplement for primary offering
4:54pm
8-K
EX-99.1
o6msobi4e 27p63
15 May 23
Cocrystal Pharma Reports First Quarter 2023 Financial Results and Provides Updates on its Antiviral Drug Development Programs
8:00am
8-K
EX-99.1
x4cncnlbkvhc1tc t2z
24 Apr 23
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors
8:13am
8-K
EX-99.1
4d2xsjlgsibwilgn1keh
10 Apr 23
Cocrystal Pharma Completes $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
8:30am
8-K
EX-99.1
yfccc
15 Aug 22
Cocrystal Pharma Reports Second Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs
8:00am
8-K
EX-99.1
e0zlmwh fxq
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
7ibm6wgi 1ta
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
huke8m
22 Dec 21
Regulation FD Disclosure
8:30am